Pharmacokinetics and Mechanism of Action
The drug is a carbonaceous material of plant or animal origin. A key technological feature of its production is special processing involving fine pulverization. This process is critical as it aims to maximize the adsorbing surface area of the preparation.
The mechanism of action of Carbo activatus relies on physicochemical binding (adsorption) of various substances directly within the lumen of the gastrointestinal tract. Acting as an enterosorbent, it contacts molecules of toxins or other drugs and fixes them onto its vast reactive surface. This interaction forms large, non-absorbable complexes that cannot physically cross the intestinal mucosa into the systemic circulation. This reliably prevents the absorption of bound substances and promotes their excretion from the body unchanged via feces.
Pharmacological Effects and Indications
The clinical use of activated charcoal stems from its high sorption capacity. It is indicated in the following scenarios:
- Acute Poisoning: Serves as a first-line emergency intervention in oral intoxications. The drug effectively adsorbs alkaloids, heavy metal salts, and toxins responsible for foodborne toxic infections within the GI tract. By binding these agents, charcoal prevents their absorption into the bloodstream and the development of severe systemic toxicity.
- Flatulence: Used for excessive gas accumulation in the intestines. The mechanism is analogous: physical adsorption of gases occurs on the surface of the carbon particles, reducing abdominal distension and relieving discomfort.
- Combination Therapy for Overdoses: In toxicology, charcoal is utilized as a standard element of care for drug overdoses. For instance, in pentoxifylline overdose (characterized by hypotension, seizures, and gastrointestinal bleeding), activated charcoal is administered into the GI tract alongside gastric lavage and supportive therapy to prevent further drug absorption.
Drug Interactions at the Absorption Stage
From a clinical pharmacology standpoint, Carbo activatus is a potent perpetrator of pharmacokinetic drug interactions at the absorption stage.
When administered orally, activated charcoal and its analogs inhibit the absorption of virtually all medicinal substances due to surface binding (adsorption) of other drug molecules. Similar to anion-exchange resins (e.g., cholestyramine) or polyvalent metal ions (calcium, magnesium, aluminum, which form chelate complexes with fluoroquinolones), charcoal leads to the formation of large complexes.
Clinical Outcome: Impaired absorption of concomitant medications $\rightarrow$ a sharp decrease or complete loss of their therapeutic efficacy. For this reason, activated charcoal must be administered in isolation, maintaining a strict time interval between its administration and that of any other oral medications.
Dosage Forms and Administration Guidelines
According to standard pharmacological references, Carbo activatus is available in two main forms:
- Powder (used to prepare suspensions).
- Tablets (0.25 g).
Administration in Acute Poisoning: The drug is given orally in high doses — 20.0–30.0 g per single administration. It is critically important to administer the drug not in dry form, but strictly as an aqueous suspension (mixed in water). This ensures immediate distribution of carbon particles across the GI mucosa and provides an immediate maximal adsorbing surface for toxin binding.